Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Heitmann

Showing results (1-10 of 72) with videos related to

Pageof 8
Sort By:
Der Pathologe|July 21, 2009
[Myositides]A Bornemann, S Heitmann, A Lindner
Praxis|May 28, 2010
[Laboratory changes in anorexia nervosa]A Baumann, S Heitmann, V Bubendorff, et al.
Anesthesiology|December 14, 2019
Tracheobronchial Polyposis after Inhalation TraumaJonas S Heitmann, Birgit Federmann, Jürgen Hetzel, et al.
Cancers|February 4, 2021
Bispecific Antibodies in Prostate Cancer Therapy: Current Status and PerspectivesJonas S Heitmann, Martin Pfluegler, Gundram Jung, et al.
Cancers|October 14, 2022
Immunopeptidome Diversity in Chronic Lymphocytic Leukemia Identifies Patients with Favorable Disease OutcomeMaddalena Marconato, Yacine Maringer, Juliane S Walz, et al.
Viruses|October 28, 2023
Long-Term Follow-Up of COVID-19 Convalescents-Immune Response Associated with Reinfection Rate and SymptomsAnna Seller, Christopher Hackenbruch, Juliane S Walz, et al.
Cellular Immunology|February 5, 2020
Genetic loss of NFAT2 (NFATc1) impairs B cell development of B1 and B2 B cellsMelanie Märklin, Jonas S Heitmann, Joseph Kauer, et al.
Scientific Reports|September 23, 2022
Expression of the immune checkpoint modulator OX40 indicates poor survival in acute myeloid leukemiaMaddalena Marconato, Joseph Kauer, Helmut R Salih, et al.
Laboratory Animals|April 26, 2000
Immunohistological characterization of leukocytes in the lungs of healthy mice and after bacterial intratracheal infectionS Heitmann, T Tschernig, M Larbig, et al.
International Journal of Hematology|April 9, 2020
CD105 (endoglin) as risk marker in AML patients undergoing stem cell transplantationMelanie Märklin, Ilona Hagelstein, Clemens Hinterleitner, et al.
Pageof 8

Showing results (1-10 of 72) with videos related to

Sort By:
Pageof 8
Der Pathologe|July 21, 2009
[Myositides]A Bornemann, S Heitmann, A Lindner
Praxis|May 28, 2010
[Laboratory changes in anorexia nervosa]A Baumann, S Heitmann, V Bubendorff, et al.
Anesthesiology|December 14, 2019
Tracheobronchial Polyposis after Inhalation TraumaJonas S Heitmann, Birgit Federmann, Jürgen Hetzel, et al.
Cancers|February 4, 2021
Bispecific Antibodies in Prostate Cancer Therapy: Current Status and PerspectivesJonas S Heitmann, Martin Pfluegler, Gundram Jung, et al.
Cancers|October 14, 2022
Immunopeptidome Diversity in Chronic Lymphocytic Leukemia Identifies Patients with Favorable Disease OutcomeMaddalena Marconato, Yacine Maringer, Juliane S Walz, et al.
Viruses|October 28, 2023
Long-Term Follow-Up of COVID-19 Convalescents-Immune Response Associated with Reinfection Rate and SymptomsAnna Seller, Christopher Hackenbruch, Juliane S Walz, et al.
Cellular Immunology|February 5, 2020
Genetic loss of NFAT2 (NFATc1) impairs B cell development of B1 and B2 B cellsMelanie Märklin, Jonas S Heitmann, Joseph Kauer, et al.
Scientific Reports|September 23, 2022
Expression of the immune checkpoint modulator OX40 indicates poor survival in acute myeloid leukemiaMaddalena Marconato, Joseph Kauer, Helmut R Salih, et al.
Laboratory Animals|April 26, 2000
Immunohistological characterization of leukocytes in the lungs of healthy mice and after bacterial intratracheal infectionS Heitmann, T Tschernig, M Larbig, et al.
International Journal of Hematology|April 9, 2020
CD105 (endoglin) as risk marker in AML patients undergoing stem cell transplantationMelanie Märklin, Ilona Hagelstein, Clemens Hinterleitner, et al.
Pageof 8